Back to Journals » OncoTargets and Therapy » Volume 8
Corrigendum
Outcomes analysis of an alternative formulation of PEGylated liposomal doxorubicin in recurrent epithelial ovarian carcinoma during the drug shortage era [Corrigendum]
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
8,143 | Dovepress* | 7,771+ | 1,566 | 9,337 | |
PubMed Central* | 372 | 136 | 508 | ||
Totals | 8,143 | 1,702 | 9,845 | ||
*Since 9 March 2015 +Since July 2016 |
View citations on PubMed Central and Google Scholar